Clinical Trials Directory

Trials / Completed

CompletedNCT04672447

Effect of 4 Weeks of Citrulline and Glutathione Supplementation on Arterial Function

Effects of 4 Weeks Supplementation With L-Citrulline and Glutathione on Arterial Function and Cardiovascular Responses in Postmenopausal Healthy Women: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Texas Tech University · Academic / Other
Sex
Female
Age
50 Years – 79 Years
Healthy volunteers
Accepted

Summary

Examining the effects of 4 weeks of Citrulline alone or in combination with glutathione on the arterial function of postmenopausal women.

Detailed description

L-Citrulline is a non-protein amino acid and an efficient precursor of L-arginine, the substrate for endothelial nitric oxide synthesis. Glutathione is a tripeptide with antioxidant effects. Postmenopausal women will ingest 6g/d of L-Citrulline or 2g of L-Citrulline plus 200mg/d of glutathione or placebo (maltodextrin) for 4 weeks with vascular function testing prior to and after the intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTL-CitrullineFour weeks of oral L-Citrulline (2 grams/day) supplementation. Supplementation will be ingested daily, half of the doses in the morning and half at night.
DIETARY_SUPPLEMENTL-CitrullineFour weeks of oral L-Citrulline (6 grams/day) supplementation. Supplementation will be ingested daily, half of the doses in the morning and half at night.
DIETARY_SUPPLEMENTPlaceboFour weeks of oral placebo (6 grams/day maltodextrin) supplementation. Supplementation will be ingested daily, half of the doses in the morning and half at night.
DIETARY_SUPPLEMENTGlutathioneFour weeks of Glutathione (200mg/day) supplementation. Supplementation will be ingested daily, half of the doses in the morning and half at night.

Timeline

Start date
2020-07-01
Primary completion
2022-04-27
Completion
2022-04-27
First posted
2020-12-17
Last updated
2022-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04672447. Inclusion in this directory is not an endorsement.